Depression

Veterans, First Responders, and families supporting psychedelic medicine will be honored at the conference for their mental health challenges and the urgent need for better care and resources.

Itzel Barakat, Justin LaPree

Overview of a multicenter trial compares psilocybin therapy to active control for demoralization in end-of-life adults. Trial focuses on treating depression, anxiety, and improving quality of life, spiritual well-being, and

Jessi Humphreys

Psilocybin's therapeutic potential for various medical conditions is being explored, including pilot studies on Alzheimer's Disease and chronic Lyme Disease. Preliminary results and participant reports inform ongoing psilocybin-assisted treatments research.

Albert Garcia-Romeu

Aaron will discuss his work with autistic adults, emphasizing neurodiversity-affirming care and the potential of psychedelic approaches to improve mental health support for autistic individuals.

Aaron Paul Orsini, Angela Carter ND, Jeanna Eichenbaum

Stanford conducted the first trial of Magnesium-Ibogaine on Special Operations Forces Veterans with traumatic brain injury, showing significant functional improvements and high remission rates for comorbid psychiatric disorders. Further controlled

Nolan Williams

Wellness and Psychedelics: Academic studies show psychedelics, in clinical settings with therapy, rapidly improve psychiatric conditions. Survey of 3,000 adults found significant improvements in mental health with psychedelic use.

Saundra Jain

Psychedelics, historically linked to "free love", show potential for positive impact on sexual feelings. Recent research suggests psilocybin may enhance sexual functioning and satisfaction in healthy and depressed individuals.

Tommaso Barba

5-MeO-DMT, a natural tryptamine, shows psychedelic effects by acting on serotonin receptors. Clinical trials suggest its potential for rapidly reducing depression symptoms, prompting further studies for depression treatment.

Johannes Reckweg

Psychedelics are studied for psychiatric disorders; research emphasizes 'set and setting.' Study explores psychosocial factors in psychedelic use, linking communal experiences to improved mental health outcomes.

Hannes Kettner

Families of veterans are affected by trauma, depression, and addiction. Session explores healing for families impacted by veterans' struggles.

Anne Wagner, Lauren Myers, Andrea Lucie